NCT06656832

Peripheral Drivers of Heart Failure Progression - the Prospective PEDAL-HF Study

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 1,000 (estimated)
• Sponsor: University of Leipzig · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

PEDAL-HF is a registry-based randomized prospective multicenter study. We plan to include 1000 patients who were recently admitted with acute decompensated heart failure at five tertiary heart clinics in Germany. For the randomised part, 750 patients will be randomized to care within a heart failure network or usual care. The primary endpoint of the randomized trial is change in NT-proBNP from baseline to 6 months of follow-up. All patients (randomized or not) will be followed for two years.

Detailed description

See above.

Conditions

• Heart Failure - NYHA II - IV

Interventions

Type	Name	Description
OTHER	Heart Failure network care	Patients will receive three visits within the first three months after randomization for improving heart failure therapy at a cardiologist or the outpatient heart failure clinic

Timeline

• Start date: 2024-11-01
• Primary completion: 2028-10-01
• Completion: 2028-12-31
• First posted: 2024-10-24
• Last updated: 2024-10-24